Article
Effect of carboxylesterase 1 S75N on clopidogrel therapy among acute coronary syndrome patients.
Scientific reports - 3 Aug 2017
Xiao Fei-Yan, Luo Jian-Quan, Liu Min, Chen Bi-Lian, Cao Shan, Liu Zhao-Qian, Zhou Hong-Hao, Zhou Gan, Zhang Wei
Abstract excerpt
Carboxylesterase 1 (CES1) hydrolyzes the prodrug clopidogrel to an inactive carboxylic acid metabolite. The effects of CES1 S75N (rs2307240,C>T) on clopidogrel response among 851 acute coronary syndrome patients who came from the north, central and south of China were studied. The occurrence ratios of each endpoint in the CC group were significantly higher than in the CT + TT group for cerebrovascular events (14%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
